These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 38785471)

  • 41. Combined effect of unrelated donor age and HLA peptide-binding motif match status on HCT outcomes.
    Mehta RS; Petersdorf EW; Spellman SR; Lee SJ
    Blood Adv; 2024 May; 8(9):2235-2242. PubMed ID: 38467032
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A study of selected hematopoietic stem cell donors provided by an intermediate size registry.
    Nicoloso G; Kürsteiner O; Bussmann F; Marbacher M; Tiercy JM
    Eur J Haematol; 2019 Oct; 103(4):426-432. PubMed ID: 31385372
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Selection of adult unrelated hematopoietic stem cell donors: beyond HLA.
    Confer DL; Abress LK; Navarro W; Madrigal A
    Biol Blood Marrow Transplant; 2010 Jan; 16(1 Suppl):S8-S11. PubMed ID: 19892026
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Phase I study of graft-versus-host disease prophylaxis including bortezomib for allogeneic hematopoietic cell transplantation from unrelated donors with one or two HLA loci mismatches in Japanese patients.
    Nakane T; Okamura H; Tagaito Y; Koh S; Yoshimura T; Makuuchi Y; Nanno S; Nakamae M; Hirose A; Nakashima Y; Koh H; Hino M; Nakamae H
    Int J Hematol; 2019 Dec; 110(6):736-742. PubMed ID: 31560116
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Donor-Specific HLA Antibodies Are Associated with Graft Failure and Delayed Hematologic Recovery after Unrelated Donor Hematopoietic Cell Transplantation.
    Lima ACM; Getz J; do Amaral GB; Loth G; Funke VAM; Nabhan SK; Petterle RR; de Marco R; Gerbase-DeLima M; Pereira NF; Bonfim C; Pasquini R
    Transplant Cell Ther; 2023 Aug; 29(8):493.e1-493.e10. PubMed ID: 37220839
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Allogeneic Hematopoietic Stem Cell Transplantation in Thirty-Four Pediatric Cases of Mucopolysaccharidosis-A Ten-Year Report from the China Children Transplant Group.
    Wang J; Luan Z; Jiang H; Fang J; Qin M; Lee V; Chen J
    Biol Blood Marrow Transplant; 2016 Nov; 22(11):2104-2108. PubMed ID: 27555533
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Incidence and Role of Recipient-Specific Antibodies in Allogeneic Hematopoietic Cell Transplantation from Mismatched Related Donors.
    Sadowska-Klasa A; Dukat-Mazurek A; Zielińska H; Dębska-Zielkowska J; Piekarska A; Moszkowska G; Mensah-Glanowska P; Zaucha JM
    Transplant Cell Ther; 2024 Jan; 30(1):99.e1-99.e10. PubMed ID: 37875214
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical implications of HLA locus mismatching in unrelated donor hematopoietic cell transplantation: a meta-analysis.
    Tie R; Zhang T; Yang B; Fu H; Han B; Yu J; Tan Y; Huang H
    Oncotarget; 2017 Apr; 8(16):27645-27660. PubMed ID: 28206973
    [TBL] [Abstract][Full Text] [Related]  

  • 49. HLA-Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide versus HLA-Matched Unrelated Donor Transplantation for Myelodysplastic Syndrome.
    Nakaya Y; Koh H; Konuma T; Shimomura Y; Ishiyama K; Itonaga H; Hino M; Doki N; Nishida T; Ohigashi H; Matsuoka KI; Kanda Y; Maruyama Y; Sawa M; Eto T; Hiramoto N; Fukuda T; Atsuta Y; Nakamae H
    Transplant Cell Ther; 2024 Mar; 30(3):316.e1-316.e12. PubMed ID: 38108263
    [TBL] [Abstract][Full Text] [Related]  

  • 50. T Cell-Replete Peripheral Blood Haploidentical Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide Results in Outcomes Similar to Transplantation from Traditionally Matched Donors in Active Disease Acute Myeloid Leukemia.
    How J; Slade M; Vu K; DiPersio JF; Westervelt P; Uy GL; Abboud CN; Vij R; Schroeder MA; Fehniger TA; Romee R
    Biol Blood Marrow Transplant; 2017 Apr; 23(4):648-653. PubMed ID: 28087457
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of antithymocyte globulin on HLA-mismatched unrelated transplantation.
    Kawamura K
    Int J Hematol; 2019 Jul; 110(1):22-29. PubMed ID: 30680666
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Graft Cryopreservation Does Not Impact Overall Survival after Allogeneic Hematopoietic Cell Transplantation Using Post-Transplantation Cyclophosphamide for Graft-versus-Host Disease Prophylaxis.
    Hamadani M; Zhang MJ; Tang XY; Fei M; Brunstein C; Chhabra S; D'Souza A; Milano F; Phelan R; Saber W; Shaw BE; Weisdorf D; Devine SM; Horowitz MM
    Biol Blood Marrow Transplant; 2020 Jul; 26(7):1312-1317. PubMed ID: 32283185
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Donor Killer Immunoglobulin Receptor Gene Content and Ligand Matching and Outcomes of Pediatric Patients with Juvenile Myelomonocytic Leukemia Following Unrelated Donor Transplantation.
    Rangarajan HG; Pereira MSF; Brazauskas R; St Martin A; Kussman A; Elmas E; Verneris MR; Gadalla SM; Marsh SGE; Paczesny S; Spellman SR; Lee SJ; Lee DA
    Transplant Cell Ther; 2021 Nov; 27(11):926.e1-926.e10. PubMed ID: 34407489
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Which factors influence the development of GVHD in HLA-matched or mismatched transplants?
    Petersdorf EW
    Best Pract Res Clin Haematol; 2017 Dec; 30(4):333-335. PubMed ID: 29156205
    [TBL] [Abstract][Full Text] [Related]  

  • 55. ABO incompatibility in mismatched unrelated donor allogeneic hematopoietic cell transplantation for acute myeloid leukemia: A report from the acute leukemia working party of the EBMT.
    Canaani J; Savani BN; Labopin M; Michallet M; Craddock C; Socié G; Volin L; Maertens JA; Crawley C; Blaise D; Ljungman PT; Cornelissen J; Russell N; Baron F; Gorin N; Esteve J; Ciceri F; Schmid C; Giebel S; Mohty M; Nagler A
    Am J Hematol; 2017 Aug; 92(8):789-796. PubMed ID: 28439910
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of the HLA Immunopeptidome on Survival of Leukemia Patients After Unrelated Donor Transplantation.
    Crivello P; Arrieta-Bolaños E; He M; Wang T; Fingerson S; Gadalla SM; Paczesny S; Marsh SGE; Lee SJ; Spellman SR; Bolon YT; Fleischhauer K
    J Clin Oncol; 2023 May; 41(13):2416-2427. PubMed ID: 36669145
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MHC Class I Chain-Related Gene A (MICA) Donor-Recipient Mismatches and MICA-129 Polymorphism in Unrelated Donor Hematopoietic Cell Transplantations Has No Impact on Outcomes in Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, or Myelodysplastic Syndrome: A Center for International Blood and Marrow Transplant Research Study.
    Askar M; Sobecks R; Wang T; Haagenson M; Majhail N; Madbouly A; Thomas D; Zhang A; Fleischhauer K; Hsu K; Verneris M; Lee SJ; Spellman SR; Fernández-Viña M
    Biol Blood Marrow Transplant; 2017 Mar; 23(3):436-444. PubMed ID: 27987385
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of the source of hematopoietic stem cell in unrelated transplants: comparison between 10/10, 9/10-HLA matched donors and cord blood.
    Granier C; Biard L; Masson E; Porcher R; Peffault de Latour R; Robin M; Boissel N; Xhaard A; Ribaud P; Lengline E; Larghero J; Charron D; Loiseau P; Socié G; Dhédin N
    Am J Hematol; 2015 Oct; 90(10):897-903. PubMed ID: 26149659
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Allogeneic transplantation for aplastic anemia.
    Eapen M
    Hematology; 2012 Apr; 17 Suppl 1():S15-7. PubMed ID: 22507769
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Demand and usage of unrelated donor products for allogeneic haematopoietic cell transplantation during the COVID-19 pandemic: A Canadian Blood Services Stem Cell Registry analysis.
    Allan DS; Green M; Morris G; Weiss J; Dibdin N; Mercer D; Seftel M
    Vox Sang; 2022 Sep; 117(9):1121-1125. PubMed ID: 35583125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.